Zhejiang Shapuaisi Pharmaceutical Stock Forum

Despite its strong recent earnings growth, the company's P/E ratio is considered quite high, which could be a potential risk to investors if the company's earnings trends do not support this kind of market sentiment in the long term.

SHSE:603168's long-term performance seems to have pleased investors, showing growth over five years. But, one warning sign for the company could impact investor sentiment.